Peter P. Stein
-
- Diabetes Treatment and Management 20
- Diabetes Management and Research 5
- Pituitary Gland Disorders and Treatments 2
- Pharmacology top 1%
- Pharmacology and Obesity Treatment 5
- Surgery top 2%
- Pancreatic function and diabetes 10
- Oncology top 5%
- Peptidase Inhibition and Analysis 5
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 11
-
- Ophthalmology and Eye Disorders 2
- Co-authors
- Keith D. KaufmanHenry R. BlackRury R. HolmanRussell ScottMichael A. NauckMichael J. DaviesFrans Van de WerfEric D. Peterson
- Journals
- Diabetes Obesity and Metabolism (5 papers)Current Medical Research and Opinion (3 papers)Metabolism (3 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Peter P. Stein
25 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Endocrinology, Diabetes and Metabolism 4.3k
- Pharmacology 752
- Surgery 1.7k
- Oncology 833
- Molecular Biology 1.8k
Countries citing papers authored by Peter P. Stein
This map shows the geographic impact of Peter P. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Stein more than expected).
Fields of papers citing papers by Peter P. Stein
This network shows the impact of papers produced by Peter P. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Stein. The network helps show where Peter P. Stein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter P. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetesbreakdown → | 2015 | 1866 |
| 2 | 2011 | 37 | |
| 3 | 2010 | 166 | |
| 4 | 2009 | 57 | |
| 5 | 2008 | 178 | |
| 6 | 2008 | 61 | |
| 7 | 2008 | 71 | |
| 8 | 2008 | 106 | |
| 9 | 2008 | 134 | |
| 10 | 2008 | 227 | |
| 11 | 2007 | 139 | |
| 12 | 2007 | 155 | |
| 13 | 2007 | 135 | |
| 14 | Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trialbreakdown → | 2007 | 529 |
| 15 | 2006 | 123 | |
| 16 | 1999 | 5 | |
| 17 | 1999 | 0 | |
| 18 | 1993 | 18 | |
| 19 | 1991 | 51 | |
| 20 | 1991 | 176 |
About Peter P. Stein
Peter P. Stein is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Surgery, Molecular Biology and Oncology, having authored 27 papers that have together received 4.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), Metabolism, Diabetes, and Cancer (11 papers), Pancreatic function and diabetes (10 papers), Peptidase Inhibition and Analysis (5 papers), Pharmacology and Obesity Treatment (5 papers), Diabetes Management and Research (5 papers), Ophthalmology and Eye Disorders (2 papers) and Pituitary Gland Disorders and Treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.3k citations), Pharmacology (752 citations), Surgery (1.7k citations), Oncology (833 citations) and Molecular Biology (1.8k citations). Peter P. Stein has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Keith D. Kaufman, Henry R. Black, Rury R. Holman, Russell Scott, Michael A. Nauck, Michael J. Davies, Frans Van de Werf, Eric D. Peterson, Robert Josse and Michael Pencina. Their work appears in journals such as Diabetes Obesity and Metabolism, Current Medical Research and Opinion, Metabolism, Diabetes Research and Clinical Practice and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.